Cargando…

Semifluorinated Alkanes as New Drug Carriers—An Overview of Potential Medical and Clinical Applications

Fluorinated compounds have been used in clinical and biomedical applications for years. The newer class of semifluorinated alkanes (SFAs) has very interesting physicochemical properties including high gas solubility (e.g., for oxygen) and low surface tensions, such as the well-known perfluorocarbons...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsagogiorgas, Charalambos, Otto, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146824/
https://www.ncbi.nlm.nih.gov/pubmed/37111696
http://dx.doi.org/10.3390/pharmaceutics15041211
_version_ 1785034671082438656
author Tsagogiorgas, Charalambos
Otto, Matthias
author_facet Tsagogiorgas, Charalambos
Otto, Matthias
author_sort Tsagogiorgas, Charalambos
collection PubMed
description Fluorinated compounds have been used in clinical and biomedical applications for years. The newer class of semifluorinated alkanes (SFAs) has very interesting physicochemical properties including high gas solubility (e.g., for oxygen) and low surface tensions, such as the well-known perfluorocarbons (PFC). Due to their high propensity to assemble to interfaces, they can be used to formulate a variety of multiphase colloidal systems, including direct and reverse fluorocarbon emulsions, microbubbles and nanoemulsions, gels, dispersions, suspensions and aerosols. In addition, SFAs can dissolve lipophilic drugs and thus be used as new drug carriers or in new formulations. In vitreoretinal surgery and as eye drops, SFAs have become part of daily clinical practice. This review provides brief background information on the fluorinated compounds used in medicine and discusses the physicochemical properties and biocompatibility of SFAs. The clinically established use in vitreoretinal surgery and new developments in drug delivery as eye drops are described. The potential clinical applications for oxygen transport by SFAs as pure fluids into the lungs or as intravenous applications of SFA emulsions are presented. Finally, aspects of drug delivery with SFAs as topical, oral, intravenous (systemic) and pulmonary applications as well as protein delivery are covered. This manuscript provides an overview of the (potential) medical applications of semifluorinated alkanes. The databases of PubMed and Medline were searched until January 2023.
format Online
Article
Text
id pubmed-10146824
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101468242023-04-29 Semifluorinated Alkanes as New Drug Carriers—An Overview of Potential Medical and Clinical Applications Tsagogiorgas, Charalambos Otto, Matthias Pharmaceutics Review Fluorinated compounds have been used in clinical and biomedical applications for years. The newer class of semifluorinated alkanes (SFAs) has very interesting physicochemical properties including high gas solubility (e.g., for oxygen) and low surface tensions, such as the well-known perfluorocarbons (PFC). Due to their high propensity to assemble to interfaces, they can be used to formulate a variety of multiphase colloidal systems, including direct and reverse fluorocarbon emulsions, microbubbles and nanoemulsions, gels, dispersions, suspensions and aerosols. In addition, SFAs can dissolve lipophilic drugs and thus be used as new drug carriers or in new formulations. In vitreoretinal surgery and as eye drops, SFAs have become part of daily clinical practice. This review provides brief background information on the fluorinated compounds used in medicine and discusses the physicochemical properties and biocompatibility of SFAs. The clinically established use in vitreoretinal surgery and new developments in drug delivery as eye drops are described. The potential clinical applications for oxygen transport by SFAs as pure fluids into the lungs or as intravenous applications of SFA emulsions are presented. Finally, aspects of drug delivery with SFAs as topical, oral, intravenous (systemic) and pulmonary applications as well as protein delivery are covered. This manuscript provides an overview of the (potential) medical applications of semifluorinated alkanes. The databases of PubMed and Medline were searched until January 2023. MDPI 2023-04-11 /pmc/articles/PMC10146824/ /pubmed/37111696 http://dx.doi.org/10.3390/pharmaceutics15041211 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tsagogiorgas, Charalambos
Otto, Matthias
Semifluorinated Alkanes as New Drug Carriers—An Overview of Potential Medical and Clinical Applications
title Semifluorinated Alkanes as New Drug Carriers—An Overview of Potential Medical and Clinical Applications
title_full Semifluorinated Alkanes as New Drug Carriers—An Overview of Potential Medical and Clinical Applications
title_fullStr Semifluorinated Alkanes as New Drug Carriers—An Overview of Potential Medical and Clinical Applications
title_full_unstemmed Semifluorinated Alkanes as New Drug Carriers—An Overview of Potential Medical and Clinical Applications
title_short Semifluorinated Alkanes as New Drug Carriers—An Overview of Potential Medical and Clinical Applications
title_sort semifluorinated alkanes as new drug carriers—an overview of potential medical and clinical applications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146824/
https://www.ncbi.nlm.nih.gov/pubmed/37111696
http://dx.doi.org/10.3390/pharmaceutics15041211
work_keys_str_mv AT tsagogiorgascharalambos semifluorinatedalkanesasnewdrugcarriersanoverviewofpotentialmedicalandclinicalapplications
AT ottomatthias semifluorinatedalkanesasnewdrugcarriersanoverviewofpotentialmedicalandclinicalapplications